Among the potent anti-fibrotic therapeutic cytokines, Interferon gamma (IFNγ) is shown to be highly efficacious in vitro and in vivo in liver fibrosis models [19], but it failed in clinical trials due to reduced efficacy and unwanted systemic effects [8]. Here, IFNG is linked to Hepatic fibrosis.